Otsuka Holdings
4578.T
#748
Rank
โ‚น2.865 T
Marketcap
โ‚น5,426
Share price
-0.19%
Change (1 day)
14.26%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Earnings for Otsuka Holdings (4578.T)

Earnings in 2023: โ‚น95.35 Billion

According to Otsuka Holdings 's latest financial reports the company's current earnings are โ‚น14.47 Billion. In 2023 the company made an earning of โ‚น95.35 Billion a decrease over its 2022 earnings that were of โ‚น120.59 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Otsuka Holdings from 2010 to 2023

Annual earnings

Year Earnings Change
2023โ‚น95.35 B-20.93%
2022โ‚น120.59 B-12.7%
2021โ‚น138.13 B-19.92%
2020โ‚น172.51 B13.9%
2019โ‚น151.46 B52.07%
2018โ‚น99.60 B11.22%
2017โ‚น89.55 B-36.03%
2016โ‚น139.98 B31.15%
2015โ‚น106.73 B
2013โ‚น221.54 B33.52%
2012โ‚น165.92 B-4.65%
2011โ‚น174.02 B45.53%
2010โ‚น119.58 B